companydata.dkcompanydata.dk

RAM BIOTECH ApS: Financial statements 2024

CVR: 26923573

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

RAM BIOTECH ApS (CVR 26923573) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -29,439 and a net result of DKK -29,439 compared with DKK -24,578 the year before. Equity in the 2024 report amounted to DKK 254,237. The solvency ratio was 90.4%.

Gross Profit
DKK -29,439
Profit/Loss
DKK -29,439
Equity
DKK 254,237
Total Assets
DKK 281,237

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--29 t.-29 t.254 t.-
2023--25 t.-25 t.284 t.-
2022--26 t.-29 t.308 t.-
2021-74 t.72 t.337 t.-
2020-47 t.47 t.265 t.0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

RAM BIOTECH ApS: The 2023 annual report is outFeb 12, 2024

RAM BIOTECH ApS has published its annual report for 2023. Gross profit came to DKK -24,547, and the net result was DKK -24,578.

About RAM BIOTECH ApS

RAM BIOTECH ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2002. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named RAM BIOTECH ApS UNDER STIFTELSE. The management consists of Morten Steen Hanefeld Dziegiel. The board consists of Leif Kofoed Nielsen (chair), Morten Steen Hanefeld Dziegiel and Rasmus Lundquist. The company is owned by Leif Kofoed Nielsen, Morten Steen Hanefeld Dziegiel and Lundquist Medical ApS. The company has 1 employee (2004). In 2025, the company reported a gross profit of DKK -22,479 and a net result of DKK -22,479 compared with DKK -29,439 the year before. Equity in the 2025 report amounted to DKK 231,758.

Source: annual report 2025, Danish Business Authority